Access cutting-edge liver cancer treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
The main goals of this study are to evaluate the safety and efficacy of casdozokitug in combination with toripalimab plus bevacizumab and to define a recommended dose for casdozokitug in combination with toripalimab plus bevacizumab.
Sponsor: Coherus Oncology, Inc.
Check if you qualify for this liver cancer clinical trial in Los Angeles, CA
If you're searching for liver cancer treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.